InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by MPM BioVentures 2014 (B), L.P.. Director active across 1 company, notably Werewolf Therapeutics, Inc.. Cumulatively, 2 disclosures have been recorded. History available since 29 June 2026. The latest transaction was disclosed on 6 July 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations